Home  >  Products  >  RAET1E (retinoic acid early transcript 1E ) Blocking Peptide (the C terminal of RAET1E)(100ug)
RAET1E (retinoic acid early transcript 1E ) Blocking Peptide (the C terminal of RAET1E)(100ug)

RAET1E (retinoic acid early transcript 1E ) Blocking Peptide (the C terminal of RAET1E)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-RAET1E Antibody (ARP65271_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP65271
Size: 100ug
Weight: 27kDa
Gene: 135250
Format: Lyophilized powder
Target: This gene belong to the RAET1 family, which consists of major histocompatibility complex (MHC) class I-related genes located in a cluster on chromosome 6q24.2-q25.3. This and RAET1G protein differ from other RAET1 proteins in that they have type I membrane-spanning sequences at their C termini rather than glycosylphosphatidylinositol anchor sequences. This protein functions as a ligand for NKG2D receptor, which is expressed on the surface of several types of immune cells, and is involved in innate and adaptive immune responses. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Alternative names: LETAL; MGC125308; MGC125309; RAET1E2; ULBP4; bA350J20.7
See Full Product Listings >